Skip to content
    BDC Capital's Thrive Venture Fund logo

    BDC Capital's Thrive Venture Fund

    Montreal, CanadaFounded 2022
    www.bdc.ca/en/bdc-capital/venture-capital/funds/thrive-platform/thrive-venture-fund
    Enterprise SoftwareBiotech & Life SciencesClimate & EnergyDefense & Space

    BDC Capital's Thrive Venture Fund is a CAD $300 million direct-investment fund making equity investments in women-led Canadian technology companies at the seed and Series A/B stages. It is part of BDC's $500 million Thrive Platform for Women, launched in 2022 as the successor to the Women in Technology Venture Fund.

    Deal activity increased 100% year-over-year (2 deals in the last 12 months). Average disclosed round size is $63.0M (across 18 rounds with reported amounts).

    Find people at BDC Capital's Thrive Venture Fund on Goldilocks AI

    Portfolio

    17

    Fund Size

    $300M

    Top Stage

    Series A

    Last 12 Mo

    2

    Team

    Mona Minhas

    Mona Minhas

    Managing Partner

    Kimberly Yeung

    Kimberly Yeung

    Partner

    SA

    Steven Abrams

    Partner

    TG

    Thomas Green

    Partner

    EX

    Emily Xu

    Associate Principal

    Phuong Bui

    Phuong Bui

    Associate

    CE

    Cassidy Emby

    Senior Analyst

    Cole Brodkin

    Cole Brodkin

    Analyst

    PR

    Perry Rizzo

    CEO — Axiom Group

    Portfolio Breakdown

    Stage Distribution

    Sector Distribution

    Investment Activity

    DealsAvg Round Size

    Portfolio

    21 investments
    CompanyRoundAmountDate
    SSprout FamilySeed$3.5MOct 2026
    Congruence Therapeutics logoCongruence TherapeuticsSeries B$39.5MMar 2026
    Waabi logoWaabiSeries C$750MJan 2026
    Eli Health logoEli HealthSeries A$17MJun 2025
    KKneadPre-Seed$800KJan 2025
    Sanctuary logoSanctuaryGrowth—Jul 2024
    MMedreddiePre-Seed$2MJan 2024
    FlipGive logoFlipGiveSeries B$5MAug 2023
    ODAIA logoODAIASeries B$25MMay 2023
    Vivid Machines logoVivid MachinesSeed$4.3MApr 2023
    Omy Laboratoires logoOmy LaboratoiresSeries A$11MApr 2023
    Congruence Therapeutics logoCongruence TherapeuticsSeries A$65MMar 2023
    Puzzle Medical Devices logoPuzzle Medical DevicesSeries A$43MJan 2023
    Symend logoSymendGrowth$42MNov 2022
    Waabi logoWaabiSeries C$83.5MJun 2021
    Blue Dot logoBlue DotSeries A$7MJan 2021
    Lillio logoLillioSeries B——
    PPuzzle MedicalSeries A$34M—
    MMedreddieSeed$1.6M—
    Fictionary logoFictionarySeed——
    Fictionary logoFictionaryPre-Seed$245K—

    Top Co-Investors

    BDC Capital3 shared
    MaRS IAF3 shared
    Radical Ventures2 shared
    Khosla Ventures2 shared
    Uber Investments2 shared
    Inovia Capital2 shared
    Export Development Canada2 shared
    TELUS Global Ventures2 shared
    Amplitude Ventures2 shared
    OrbiMed2 shared
    Desjardins Capital2 shared
    Right Side Capital Management2 shared
    The512 shared
    8VC1 shared
    OMERS Ventures1 shared
    Tau Ventures1 shared
    Alumni Ventures1 shared
    BDC Capital's Women in Technology Venture Fund1 shared
    Graphene Ventures1 shared
    Wittington Ventures1 shared

    Last updated: 20 October 2026